← Back to all trials
Recruiting
NCT07403331
An Integrated Intervention of Spinal Cord Stimulation and Multidisciplinary Rehabilitation for Chronic Neuropathic Leg Pain: A Single-case Experimental Design Protocol
Conditions: Neuropathic Pain, Multidisciplinary Approach, Rehabilitation Exercise, Acceptance & Commitment Therapy, Spinal Cord Stimulation (SCS)
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 10
Sponsor: Oslo University Hospital
Location: Department of pain management and research, Oslo university hospital Oslo
Summary
People with nerve damage can develop nerve pain. The pain can sometimes be severe and unpredictable, causing odd or alarming sensations - for example, lightning-like or electric shock feelings in the area served by the damaged nerve.
The investigators will examine a treatment for nerve pain in the legs caused by nerve damage, which can occur after a herniated disc or a bone fracture, with or without surgery.
Previous research suggests that spinal cord stimulation can relieve nerve pain in the legs after surgery or injury, but its effectiveness is still debated. Other studies show that multidisciplinary treatment helps people with long-term pain to improve their quality of life and to better cope in life. National and international guidelines recommend this kind of multidisciplinary care for long-term pain.
There has yet been published research on spinal cord stimulation combined with multidisciplinary treatment as a bundle intervention. The investigators therefore want to find out whether this combined approach can reduce nerve pain in the legs and improve physical functioning.
Eligibility Criteria
Inclusion criteria:
* Peripheral neuropathic pain in one or both legs for \>6 months due to:
* (1) Post Spinal Pain Syndrome (type 1 or 2).
* (2) Localized nerve damage.
* The area of the neuropathic pain in the leg(s) must be the dominant pain component.
* Age ranges from 18-60 years.
* Previous standard conservative (or surgical) treatment attempted.
* Opioid use within permissible limits at implantation time (daily opioid dose \
Source: ClinicalTrials.gov (NCT07403331). StuddyBuddy aggregates publicly available trial information.